Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico.

ABSTRACT: An estimated 2 million inhabitants are infected with Chagas disease in Mexico, with highest prevalence coinciding with highest demographic density in the southern half of the country. After vector-borne transmission, Trypanosoma cruzi is principally transmitted to humans via blood transfusion. Despite initiation of serological screening of blood donations or donors for T. cruzi since 1990 in most Latin American countries, Mexico only finally included mandatory serological screening nationwide in official Norms in 2012. Most recent regulatory changes and segmented blood services in Mexico may affect compliance of mandatory screening guidelines. The objective of this study was to calculate the incremental cost-effectiveness ratio for total compliance of current guidelines from both Mexican p

SUBMITTER: Sanchez-Gonzalez G 

PROVIDER: S-EPMC4803194 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature